News & Press Releases

Cellerant Therapeutics Appoints Ramkumar Mandalam as Vice President of Pharmaceutical Operations
November 1, 2005

Cellerant Adds $9 Million to Series B Round for a Total of $25 Million
September 22, 2005

FierceBiotech Honors Cellerant Therapeutics as One of the “Fierce 15" Biotech Companies of 2005
June 21, 2005

Cellerant Therapeutics Raises $16 million to advance stem cell-based therapies for life-threatening diseases
May 11, 2005

Cellerant Therapeutics has moved
May 2, 2005

Cellerant Therapeutics Profiled in Nature Bioentrepreneur (registration required)
February 24, 2005

Cellerant Therapeutics Presents Preclinical Data Demonstrating Therapeutic Benefit of Expanded Myeloid Progenitors at 2005 Tandem BMT Meetings
February 14, 2005